Loading...
XETR
SBS
Market cap259mUSD
Jul 09, Last price  
18.66EUR
1D
4.01%
1Q
5.07%
Jan 2017
-59.25%
Name

Stratec SE

Chart & Performance

D1W1MN
XETR:SBS chart
P/E
—
P/S
0.90
EPS
—
Div Yield, %
3.22%
Shrs. gr., 5y
—
Rev. gr., 5y
0.06%
Revenues
251m
-2.62%
067,527,00067,527,00079,589,000106,732,000122,197,000122,424,000127,950,000144,860,000146,886,000184,911,000209,764,000187,819,000221,641,000250,099,000287,335,000274,625,000270,414,000257,624,000250,863,000
Net income
-242k
L
006,131,00011,674,00013,039,00015,282,00013,973,00015,478,00019,768,00022,084,00019,572,00025,635,0008,969,00014,440,00025,175,00039,958,00029,223,00015,370,00016,021,000-242,000
CFO
-433k
L
8,827,0009,567,8804,690,00010,878,0001,448,00010,707,0002,720,00023,837,00039,752,00026,033,00016,256,00029,981,00011,950,00021,262,00031,849,00063,473,00010,279,00019,425,00048,712,000-432,999
Dividend
Jun 30, 20250.6 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
URL
https://www.stratec.com/
IPO date
Aug 25, 1998
Employees
1,512
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT